Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)

BACKGROUND: The objective of this study is to assess cases of thrombocytopenia, including immune thrombocytopenia (ITP), reported to the Vaccine Adverse Event Reporting System (VAERS) following vaccination with mRNA COVID-19 vaccines. METHODS: This case-series study analyzed VAERS reports of thrombo...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsh, Kerry J., Baumblatt, Jane, Chege, Wambui, Goud, Ravi, Nair, Narayan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086806/
https://www.ncbi.nlm.nih.gov/pubmed/34006408
http://dx.doi.org/10.1016/j.vaccine.2021.04.054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086806/
https://www.ncbi.nlm.nih.gov/pubmed/34006408
http://dx.doi.org/10.1016/j.vaccine.2021.04.054

Ejemplares similares